RE: MTBE misclassified
Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also...
Gespeichert in:
Veröffentlicht in: | American journal of industrial medicine 2001-05, Vol.39 (5), p.509-510 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 510 |
---|---|
container_issue | 5 |
container_start_page | 509 |
container_title | American journal of industrial medicine |
container_volume | 39 |
creator | Mirer, Franklin E. |
description | Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures. |
doi_str_mv | 10.1002/ajim.1045 |
format | Article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajim_1045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_D6VG191H_D</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</originalsourceid><addsrcrecordid>eNp1jztPwzAYRS0EoqUwsDCirgyh_vyM2foIbVELEopgtJzYllwaUcUg6L8nUSqYmO4dzr3SQegS8C1gTEZmE6qmMX6E-oCVTDCR7Bj1m4CE8lT00FmMG4wBmGCnqAdAKWVA--jqObsbrvNJNqxCLLcmxuCDs-foxJttdBeHHKD8Psuni2T1NF9Ox6ukpFzxhErGrbDWW-ZtkRphOaREFqQASpS0XqQMCCtK50pX-BQrTIjClhoDRgEdoJvutqzfY6yd17s6VKbea8C6VdOtmm7VGva6Y3efReXsH3lwaYBRB3yFrdv__6THD8v14TLpFiF-uO_fhanftJBUcv36ONcz8TIHBQs9oz-ja2Tx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>RE: MTBE misclassified</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Mirer, Franklin E.</creator><creatorcontrib>Mirer, Franklin E.</creatorcontrib><description>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</description><identifier>ISSN: 0271-3586</identifier><identifier>EISSN: 1097-0274</identifier><identifier>DOI: 10.1002/ajim.1045</identifier><identifier>PMID: 11333413</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Carcinogens ; Environmental Exposure ; Gasoline ; Humans ; Methyl Ethers - pharmacology</subject><ispartof>American journal of industrial medicine, 2001-05, Vol.39 (5), p.509-510</ispartof><rights>Copyright © 2001 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</citedby><cites>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajim.1045$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajim.1045$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11333413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirer, Franklin E.</creatorcontrib><title>RE: MTBE misclassified</title><title>American journal of industrial medicine</title><addtitle>Am. J. Ind. Med</addtitle><description>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</description><subject>Carcinogens</subject><subject>Environmental Exposure</subject><subject>Gasoline</subject><subject>Humans</subject><subject>Methyl Ethers - pharmacology</subject><issn>0271-3586</issn><issn>1097-0274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1jztPwzAYRS0EoqUwsDCirgyh_vyM2foIbVELEopgtJzYllwaUcUg6L8nUSqYmO4dzr3SQegS8C1gTEZmE6qmMX6E-oCVTDCR7Bj1m4CE8lT00FmMG4wBmGCnqAdAKWVA--jqObsbrvNJNqxCLLcmxuCDs-foxJttdBeHHKD8Psuni2T1NF9Ox6ukpFzxhErGrbDWW-ZtkRphOaREFqQASpS0XqQMCCtK50pX-BQrTIjClhoDRgEdoJvutqzfY6yd17s6VKbea8C6VdOtmm7VGva6Y3efReXsH3lwaYBRB3yFrdv__6THD8v14TLpFiF-uO_fhanftJBUcv36ONcz8TIHBQs9oz-ja2Tx</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Mirer, Franklin E.</creator><general>John Wiley & Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200105</creationdate><title>RE: MTBE misclassified</title><author>Mirer, Franklin E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Carcinogens</topic><topic>Environmental Exposure</topic><topic>Gasoline</topic><topic>Humans</topic><topic>Methyl Ethers - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirer, Franklin E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of industrial medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirer, Franklin E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RE: MTBE misclassified</atitle><jtitle>American journal of industrial medicine</jtitle><addtitle>Am. J. Ind. Med</addtitle><date>2001-05</date><risdate>2001</risdate><volume>39</volume><issue>5</issue><spage>509</spage><epage>510</epage><pages>509-510</pages><issn>0271-3586</issn><eissn>1097-0274</eissn><abstract>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>11333413</pmid><doi>10.1002/ajim.1045</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0271-3586 |
ispartof | American journal of industrial medicine, 2001-05, Vol.39 (5), p.509-510 |
issn | 0271-3586 1097-0274 |
language | eng |
recordid | cdi_crossref_primary_10_1002_ajim_1045 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Carcinogens Environmental Exposure Gasoline Humans Methyl Ethers - pharmacology |
title | RE: MTBE misclassified |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T03%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RE:%20MTBE%20misclassified&rft.jtitle=American%20journal%20of%20industrial%20medicine&rft.au=Mirer,%20Franklin%20E.&rft.date=2001-05&rft.volume=39&rft.issue=5&rft.spage=509&rft.epage=510&rft.pages=509-510&rft.issn=0271-3586&rft.eissn=1097-0274&rft_id=info:doi/10.1002/ajim.1045&rft_dat=%3Cistex_cross%3Eark_67375_WNG_D6VG191H_D%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11333413&rfr_iscdi=true |